Pinz Capital Management, LP Axsome Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$19.91 - $68.26 $31,856 - $109,216
-1,600 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$50.63 - $73.5 $81,008 - $117,600
1,600 New
1,600 $108,000
Q1 2020

May 12, 2020
SELL
$41.2 - $101.31 $1.84 Million - $4.52 Million
-44,600 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$16.71 - $106.24 $745,266 - $4.74 Million
44,600 New
44,600 $4.61 Million

Others Institutions Holding AXSM

# of Institutions
325
Shares Held
37.7M
Call Options Held
912K
Put Options Held
855K
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email